Every other month DMRF Canada publishes Going Forward; our bi-monthly e-newsletter.
What's Making News
DMRF Canada is pleased to announce the launch of an annual one-year clinical fellowship to support the training of exceptionally qualified physicians in preparation for their clinical career in movement disorders with a focus on dystonia and a special competence in use of botulinum toxins. In 2017, this program will support fellows through a grant from Allergan.
According to the research, the childhood-onset motor disorder DYT6 dystonia is caused by loss-of-function mutations in the transcription factor THAP1, but the neurodevelopmental processes in which THAP1 participates are unknown.
Researchers at the University of California San Diego have developed a model and hypothesis to explain the origins of blepharospasm, a focal dystonia of the eyelid and brow muscles that cause involuntary blinking and eye closure.